WallStreetZenWallStreetZen

NASDAQ: PRQR
Proqr Therapeutics Nv Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Proqr Therapeutics Nv revenue was $19.23M for the trailing 12 months ending Dec 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $5.5M, up 61.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, PRQR annual revenue was $19.2M, with -5.5% growth year-over-year.

PRQR past revenue growth

How has PRQR's revenue growth performed historically?

Company
-5.54%
Industry
378.66%
Market
88.33%
PRQR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PRQR's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PRQR's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PRQR revenue history

Current Revenue
$19.2M
Current Earnings
-$49.6M
Current Profit Margin
-258.1%

Be the first to know when PRQR announces revenue.

PRQR Revenue History By Year

PRQR Yearly RevenuePRQR RevenuePRQR ChangePRQR Revenue Growth
2025-12-31$19.23M-$1.13M-5.54%
2024-12-31$20.36M$9.78M+92.37%
2023-12-31$10.58M$5.95M+128.23%
2022-12-31$4.64M$1.93M+71.61%
2021-12-31$2.70M-$8.82M-76.56%
2020-12-31$11.53M$9.35M+430.72%
2019-12-31$2.17M-$4.45M-67.20%
2018-12-31$6.62M$4.83M+268.96%
2017-12-31$1.79M-$129.49k-6.73%
2016-12-31$1.92M-$1.59M-45.22%
2015-12-31$3.51M$3.13M+826.94%
2014-12-31$378.93k$219.38k+137.49%
2013-12-31$159.56kN/AN/A

1 of 1

Proqr Therapeutics Nv Revenue FAQ

What was PRQR's revenue last quarter?

On Invalid Date, Proqr Therapeutics Nv (NASDAQ: PRQR) reported Q4 2025 revenue of $5.55 million up 19.88% year over year. In the same quarter last year, Proqr Therapeutics Nv's revenue was $4.63 million.

What was Proqr Therapeutics Nv's revenue in 2025?

Proqr Therapeutics Nv's annual revenue for the twelve months ending Dec 31, 2025 was $19.23 million, a 5.54% decrease year over year.

How much does Proqr Therapeutics Nv make in a day?

Based on Proqr Therapeutics Nv annual revenue for the past five years, PRQR makes an average of $31,514.51 per day.

What was Proqr Therapeutics Nv's annual revenue growth in the past year?

As of Q1 2026, Proqr Therapeutics Nv's revenue has grown -5.54% year over year. This is 384.2 percentage points lower than the US Biotechnology industry revenue growth rate of 378.66%. Proqr Therapeutics Nv's revenue in the past year totaled $19.23 million.

How much does Proqr Therapeutics Nv make in a year?

Proqr Therapeutics Nv's revenue by year for the past five years is:
  • Proqr Therapeutics Nv's revenue for the twelve months ending Dec 31, 2025 was $19.23 million, a 5.54% decrease year over year.
  • Proqr Therapeutics Nv's annual revenue for Dec 31, 2024 was $20.36 million, a 92.37% increase from 2023.
  • Proqr Therapeutics Nv's annual revenue for 2023 was $10.58 million, a 128.23% increase from 2022.
  • Proqr Therapeutics Nv's annual revenue for 2022 was $4.64 million, a 71.61% increase from 2021.
  • Proqr Therapeutics Nv's annual revenue for 2021 was $2.70 million, a 76.56% decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.